NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹142 Cr | ₹213 Cr | ₹296 Cr | ₹126 Cr | ₹249 Cr |
What is the latest Total Non-Current Liabilities ratio of NECTAR LIFESCIENCES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹142 Cr |
Mar2023 | ₹213 Cr |
Mar2022 | ₹296 Cr |
Mar2021 | ₹126 Cr |
Mar2020 | ₹249 Cr |
How is Total Non-Current Liabilities of NECTAR LIFESCIENCES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹142 Cr | -33.60 | |
Mar2023 | ₹213 Cr | -28.07 | |
Mar2022 | ₹296 Cr | 134.39 | |
Mar2021 | ₹126 Cr | -49.29 | |
Mar2020 | ₹249 Cr | - |
Compare Total Non-Current Liabilities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹722.9 Cr | -13.8% | -13.1% | -3.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,744.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,209.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹117,762.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,705.3 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,929.3 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | -13.8% |
-13.1% |
-3.4% |
SENSEX | 0.3% |
-1.8% |
8.6% |
You may also like the below Video Courses